Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.

Author: FairfieldCameron, HarrisonEwen M, PenningaLuit, PowellJames, WigmoreStephen J

Paper Details 
Original Abstract of the Article :
BACKGROUND: Liver transplantation is an established treatment option for end-stage liver failure. Now that newer, more potent immunosuppressants have been developed, glucocorticosteroids may no longer be needed and their removal may prevent adverse effects. OBJECTIVES: To assess the benefits and ha...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD007606.pub3

データ提供:米国国立医学図書館(NLM)

Glucocorticosteroids: A Shifting Sands Debate

The world of [liver transplantation] is a complex landscape, much like a shifting desert. This research explores the role of [glucocorticosteroids] in immunosuppression following liver transplantation. It's a debate about the best way to navigate the delicate balance between suppressing the immune system and minimizing side effects. The authors conducted a [systematic review] of [randomized clinical trials] to assess the benefits and harms of [glucocorticosteroid avoidance or withdrawal] versus [glucocorticosteroid-containing immunosuppression] after liver transplantation. This study highlights the potential [benefits and risks] of different treatment approaches.

Navigating the Risks and Rewards

The review suggests that [glucocorticosteroid avoidance or withdrawal] might [reduce the risk of certain side effects], such as [diabetes mellitus] and [hypertension]. However, it also appears to [increase the risk of other complications], such as [acute rejection] and [glucocorticosteroid-resistant rejection]. The authors found that the quality of evidence is limited, and more research is needed to fully understand the long-term effects of these different approaches.

Finding the Right Path in the Sand

This research emphasizes the need for careful consideration when making decisions about [glucocorticosteroid use] following liver transplantation. It's like choosing the right path through a desert. It's important to weigh the potential risks and benefits of each approach and consult with a medical professional to determine the best course of action for your individual situation.

Dr. Camel's Conclusion

The use of glucocorticosteroids after liver transplantation remains a complex and evolving area. Like a desert landscape, the landscape of immunosuppression is constantly shifting, and more research is needed to find the most effective and safe approaches. This review highlights the importance of individualized care and careful consideration of all options.

Date :
  1. Date Completed 2016-04-28
  2. Date Revised 2021-12-03
Further Info :

Pubmed ID

26666504

DOI: Digital Object Identifier

10.1002/14651858.CD007606.pub3

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.